Inflammatory skin and bowel disease linked to ADAM17 deletion

Diana C Blaydon, Paolo Biancheri, Wei-Li Di, Vincent Plagnol, Rita M Cabral, Matthew A Brooke, David A van Heel, Franz Ruschendorf, Mark Toynbee, Amanda Walne, Edel A O'Toole, Joanne E Martin, Keith Lindley, Tom Vulliamy, Dominic J Abrams, Thomas T MacDonald, John I Harper, David P Kelsell

Research output: Contribution to journalArticlepeer-review

271 Citations (Scopus)


We performed genetic and immunohistochemical studies in a sister and brother with autosomal recessive neonatal inflammatory skin and bowel lesions. The girl died suddenly at 12 years of age from parvovirus B19-associated myocarditis; her brother had mild cardiomyopathy. We identified a loss-of-function mutation in ADAM17, which encodes a disintegrin and metalloproteinase 17 (also called tumor necrosis factor α [TNF-α]-converting enzyme, or TACE), as the probable cause of this syndrome. Peripheral-blood mononuclear cells (PBMCs) obtained from the brother at 17 years of age showed high levels of lipopolysaccharide-induced production of interleukin-1β and interleukin-6 but impaired release of TNF-α. Despite repeated skin infections, this young man has led a relatively normal life. (Funded by Barts and the London Charity and the European Commission Seventh Framework Programme.).

Original languageEnglish
Pages (from-to)1502-1508
Number of pages7
JournalNew England Journal of Medicine
Issue number16
Publication statusPublished - 20 Oct 2011


  • ADAM Proteins/genetics
  • ADAM17 Protein
  • Adolescent
  • Child
  • Fatal Outcome
  • Female
  • Humans
  • Inflammatory Bowel Diseases/genetics
  • Male
  • Myocarditis/genetics
  • Pedigree
  • Sequence Deletion
  • Skin Diseases/genetics

Cite this